Sleep and Adolescent Vaccine Immunogenicity Pilot/Observational Study
Children's Hospital Medical Center, Cincinnati · NCT07636525
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 11–12 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 66
- US sites recruiting
- 1
- Study start
- July 1, 2026
- Record last updated
- October 19, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study tests whether the sleep habits of 11-12 years-olds impact their response to a vaccine that protects against meningococcal illness. That vaccine is typically given at that age by primary care doctors, but nobody has studied how sleep affects children's response to it. This could be important because research on adults suggests that sleep affects the immune system.
Families will have their child keep their regular sleep schedule during the 5-week study. They will wear a special wristwatch at night to track their sleep. Each day they will fill out a short online form. They and a parent/guardian will come to Cincinnati Children's twice for 1 - 1 ½ hours. During the first visit, the child get the vaccine. During the second, they have a blood test.
Conditions: Vaccination
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Healthy 11-12 years olds who have neither had initial meningococcal vaccination nor known exposure to meningococcal illness.
Exclusion Criteria
- Condition or treatment resulting in immunosuppression
- Prior severe vaccine reaction
- Symptoms of clinical insomnia or organic sleep disorder
- Known neurologic condition or intellectual/developmental disability
- Use of a medication that impacts sleep
- Average nightly sleep of 8-8.99 hours (between the two groups)
- Daily intake of >1 coffee or "energy drink" or >2 caffeinated sodas.
Recruiting US locations
Cincinnati Children's Hospital Medical Center
Cincinnati, OH 45229
Site contact: Dean Beebe, Ph.D. · 513-636-3489 · dean.beebe@cchmc.org
Study contacts (from the official record)
- Dean W Beebe, PhD · 513-636-3489 · dean.beebe@cchmc.org
Similar studies in Ohio
All sleep studies in Ohio →- Recruiting
Janus II Feasibility
Zoll Medical Corporation
- Location
- Columbus, OH + 3 other US sites
- Eligibility basics
- Ages 22+
- RecruitingPhase 3
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
Axsome Therapeutics, Inc.
- Location
- Cincinnati, OH + 35 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea.
Incannex Healthcare Ltd
- Location
- Cincinnati, OH + 11 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2/Phase 3
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Alkermes, Inc.
- Location
- Canton, OH + 32 other US sites
- Eligibility basics
- Ages 18–70